Noze Receives $1 Million Grant from Major Global Foundation to Build the World's First Breathalyzer to Detect Infectious Diseases
Summary
Exhaled breath offers an incredibly revealing picture of a persons current health due to the efficient exchange that takes place between the blood and the air in the lungs. Many different diseases are represented in the breath through their unique metabolic biomarkers, which will now be targeted via Nozes platform enabling instant, low-cost and ubiquitous diagnostics.The long-term goal of the initiative is to enable global access to a reliable detection device that can help reduce the spread of diseases, identify the need for treatment as early as possible, and improve patient outcomes in developing countries.Underpinned by its exclusive license to NASA patents, Noze continues to innovate and evolve its AI-powered digital odor perception platform with a specialized focus on medical and health conditions. "Malaria is one of the worlds most severe public health problems, and is a leading cause of death and disease in many developing countries, with young children and pregnant women being the groups most affected. Built on a foundation of NASA-patented technology previously deployed to the International Space Station, its platform offers an innovative solution for the non-invasive screening and diagnostics of medical conditions through breath and body odor. Utilizing cutting-edge machine perception and a revolutionary sensor, Noze aims to enable healthcare professionals to detect potential health risks, monitor the progression of medical conditions, and improve patient outcomes.